News Release
PKD Clinic Named a Center of ExcellenceThe PKD (polycystic kidney disease) Foundation has named The University of Kansas Health System’s PKD clinic as a Center of Excellence.
News Release
COVID-19 Public Health Emergency to ExpireExpanded Medicaid eligibility and access to care due to the public health emergency will expire in May, our experts are dedicated to helping those affected understand and navigate the transition.
News Release
Expanded Pediatric Services Available in ShawneeThe University of Kansas Health System offers expanded pediatric services at our KU MedWest location.
News Release
Health System Now Offers Text MessagingYou can now text message your primary care, pediatrics, cardiovascular or pre-anesthesia doctors offices at the health system.
News Release
Breast Surgical Oncologist Jamie Wagner, DO, Brings Specialized Expertise to Olathe Health Cancer CenterJamie Wagner, DO, a fellowship-trained breast surgical oncologist, brings her specialized expertise to Olathe Health Cancer Center. She offers a multidisciplinary breast clinic that provides comprehensive care to patients with breast cancer.
News Release
NORD® Rare Disease Center of Excellence DesignationThe University of Kansas Health System, Children’s Mercy and the University of Kansas Medical Center announced they have been designated a NORD® Rare Disease Center of Excellence by the National Organization for Rare Disorders (NORD®).
News Release
Extended Weekday Hours for Orthopedic InjuriesWe are now offering extended weekday hours to care for your orthopedic urgent needs. Our experts are available at the Indian Creek Campus Monday–Thursday until 7 p.m., by appointment.
News Release
Cancer center joins exclusive clinical trials networkExperimental Therapeutics Clinical Trials Network (ETCTN) membership will increase the number of early-stage clinical trials KU Cancer Center can offer to people with cancer.
News Release
CicloMed Announces FDA Clearance of IND Application for Ciclopirox Prodrug in the Treatment of Bladder CancerCicloMed LLC announced that its development candidate for non-muscle-invasive and muscle-invasive bladder cancer, Ciclopirox Prodrug, was cleared by the U.S. Food and Drug Administration to begin human clinical trials. With this clearance, CicloMed p...
News Release
Exosomes Possible Biomarker for Targeted Sarcoma TherapyResearchers at The University of Kansas Cancer Center are studying tiny vesicles that may help lead to more targeted cancer therapies. Also called exosomes, these microvesicles act as "fingerprints" of a tumor's identity, providing early clues to can...